Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Colombel, Jean-Frédéric"" wg kryterium: Autor


Tytuł :
Physician Practice Patterns in Holding Inflammatory Bowel Disease Medications due to COVID-19, in the SECURE-IBD Registry.
Autorzy :
Agrawal M; The Henry D. Janowitz Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Brenner EJ; University of North Carolina, Department of Pediatrics, Chapel Hill, NC, USA.
Zhang X; University of North Carolina, Department of Pediatrics, Chapel Hill, NC, USA.
Colombel JF; The Henry D. Janowitz Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Kappelman MD; University of North Carolina, Department of Pediatrics, Chapel Hill, NC, USA.
Ungaro RC; The Henry D. Janowitz Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Gearry RB
Kalpan GG
Kissous-Hunt M
Lewis JD
Ng SC
Rahier JF
Reinisch W
Ruemmele FM
Steinwurz F
Underwood FE
Pokaż więcej
Corporate Authors :
SECURE-IBD Advisory Committee including
Źródło :
Journal of Crohn's & colitis [J Crohns Colitis] 2021 May 04; Vol. 15 (5), pp. 860-863.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
The impact of vedolizumab on COVID-19 outcomes among adult IBD patients in the SECURE-IBD registry.
Autorzy :
Agrawal M; The Henry D. Janowitz Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York NY.
Zhang X; Department of Pediatrics, University of North Carolina at Chapel Hill, Chapel Hill, NC.
Brenner EJ; Department of Pediatrics, University of North Carolina at Chapel Hill, Chapel Hill, NC.
Ungaro RC; The Henry D. Janowitz Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York NY.
Kappelman MD; Department of Pediatrics, University of North Carolina at Chapel Hill, Chapel Hill, NC.
Colombel JF; The Henry D. Janowitz Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York NY.
Pokaż więcej
Źródło :
Journal of Crohn's & colitis [J Crohns Colitis] 2021 Apr 22. Date of Electronic Publication: 2021 Apr 22.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Results of the Seventh Scientific Workshop of ECCO: Precision medicine in IBD- prediction and prevention of inflammatory bowel disease.
Autorzy :
Torres J; Division of Gastroenterology, Hospital Beatriz Ângelo, Loures, Portugal.; Faculdade de Medicina, Universidade de Lisboa, Portugal.
Halfvarson J; Department of Gastroenterology, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.
Rodríguez-Lago I; Department of Gastroenterology, Hospital de Galdakao, and Biocruces Bizkaia Health Research Institute, Bilbao, Spain.
Hedin CRH; Karolinska Institutet, Department of Medicine Solna, Stockholm, Sweden.; Division of Gastroenterology, Medical Unit Gastroenterology, Dermatovenereology and Rheumatology, Karolinska University Hospital, Stockholm, Sweden.
Jess T; Department of Epidemiology Research, Statens Serum Institut, Copenhagen S, Denmark.; Institute of Clinical Medicine, Aalborg University, Aalborg, Denmark.
Dubinsky M; Division of Pediatric Gastroenterology and Nutrition, Susan and Leonard Feinstein Inflammatory Bowel Disease Clinical Center, Icahn School of Medicine Mount Sinai, New York, New York.
Croitoru K; Center for Inflammatory Bowel Disesae, Mount Sinai Hospital, Toronto, Ontario, Canada, Division of Gastroenterology and Hepatology, University of Toronto, Toronto, Ontario, Canada.
Colombel JF; Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Verstockt B; University Hospitals Leuven Department of Gastroenterology and Hepatology, KU Leuven, Leuven, Belgium.; KU Leuven Department of Chronic Diseases, Metabolism and Ageing, Translational Research Center for Gastrointestinal Disorders (TARGID), Leuven, Belgium.
Fiocchi C; Department of Inflammation & Immunity, Lerner Research Institute, and Department of Gastroenterology, Hepatology & Nutrition, Digestive Disease Institute, Cleveland Clinic, Cleveland, USA.
Scharl M; Department of Gastroenterology and Hepatology, University Hospital Zürich, Switzerland.
Pokaż więcej
Źródło :
Journal of Crohn's & colitis [J Crohns Colitis] 2021 Mar 17. Date of Electronic Publication: 2021 Mar 17.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
SARS-CoV-2 vaccination in IBD: past lessons, current evidence and future challenges.
Autorzy :
Wellens J; Translational Gastro-intestinal Unit, Nuffield Department of Medicine, John Radcliffe Hospital, Oxford.; Translational Research for Gastrointestinal Diseases, University hospitals Leuven, Herestraat, Leuven, Belgium.
Colombel JF; Department of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York city, New York, USA. One Gustavo L. Levy Place, New York, NY, USA.
Satsangi JJ; Lee Placito of Gastroenterology, Translational Gastro-intestinal Unit, Nuffield Department of Medicine, John Radcliffe Hospital, Oxford.
Wong SY; The Henry D. Janowitz Division of Gastroenterology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, USA.
Pokaż więcej
Źródło :
Journal of Crohn's & colitis [J Crohns Colitis] 2021 Mar 15. Date of Electronic Publication: 2021 Mar 15.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Outcomes of Passable and Non-Passable Strictures in Clinical Trials of Crohn's Disease: A Post-hoc Analysis.
Autorzy :
Narula N; Department of Medicine (Division of Gastroenterology) and Farncombe Family Digestive Health Research Institute; McMaster University, Hamilton ON, Canada.
Wong ECL; Department of Medicine (Division of Gastroenterology) and Farncombe Family Digestive Health Research Institute; McMaster University, Hamilton ON, Canada.
Dulai PS; Division of Gastroenterology, University of California San Diego, La Jolla, CA, USA.
Marshall JK; Department of Medicine (Division of Gastroenterology) and Farncombe Family Digestive Health Research Institute; McMaster University, Hamilton ON, Canada.
Colombel JF; Division of Gastroenterology; Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Reinisch W; Department of Internal Medicine III, Division of Gastroenterology and Hepatology, Medical University of Vienna, Währinger Gürtel, Vienna, Austria.
Pokaż więcej
Źródło :
Journal of Crohn's & colitis [J Crohns Colitis] 2021 Mar 06. Date of Electronic Publication: 2021 Mar 06.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Week 6 Calprotectin Best Predicts Likelihood of Long-term Endoscopic Healing in Crohn's Disease: A Post-hoc Analysis of the UNITI/IM-UNITI Trials.
Autorzy :
Narula N; Department of Medicine [Division of Gastroenterology] and Farncombe Family Digestive Health Research Institute, McMaster University, Hamilton, ON, Canada.
Wong ECL; Department of Medicine [Division of Gastroenterology] and Farncombe Family Digestive Health Research Institute, McMaster University, Hamilton, ON, Canada.
Dulai PS; Division of Gastroenterology, University of California San Diego, La Jolla, CA, USA.
Marshall JK; Department of Medicine [Division of Gastroenterology] and Farncombe Family Digestive Health Research Institute, McMaster University, Hamilton, ON, Canada.
Colombel JF; Division of Gastroenterology; Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Reinisch W; Department of Internal Medicine III, Division of Gastroenterology and Hepatology, Medical University of Vienna, Vienna, Austria.
Pokaż więcej
Źródło :
Journal of Crohn's & colitis [J Crohns Colitis] 2021 Mar 05; Vol. 15 (3), pp. 462-470.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Prevalence and progression of incidental terminal ileitis on non-diagnostic colonoscopy: a systematic review and meta-analysis.
Autorzy :
Agrawal M; The Henry D. Janowitz Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, NY.
Bento-Miranda M; Hospital and University Center of Coimbra, Coimbra, Portugal.
Walsh S; Levy Library, Icahn School of Medicine at Mount Sinai, New York, NY.
Narula N; Department of Medicine (Division of Gastroenterology) and Farncombe Family Digestive , Health Research Institute; McMaster University, Hamilton ON, Canada.
Colombel JF; The Henry D. Janowitz Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, NY.
Ungaro RC; The Henry D. Janowitz Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, NY.
Pokaż więcej
Źródło :
Journal of Crohn's & colitis [J Crohns Colitis] 2021 Feb 14. Date of Electronic Publication: 2021 Feb 14.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Luminal narrowing alone allows an accurate diagnosis of Crohn's disease small bowel strictures at cross-sectional imaging.
Autorzy :
Stocker D; BioMedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, NY, United States.; Institute of Diagnostic and Interventional Radiology, University Hospital Zurich and University of Zurich, Zurich, Switzerland.
King MJ; Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, New York, NY, United States.
El Homsi M; Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, New York, NY, United States.
Carbonell G; BioMedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, NY, United States.; Department of Radiology, Virgen de la Arrixaca University Clinical Hospital, University of Murcia, Murcia, Spain.
Bane O; BioMedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, NY, United States.
Cuevas J; BioMedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, NY, United States.
Liu Q; Department of Pathology, Molecular and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, United States.
Cho J; Charles Bronfman Institute for Personalized Medicine, Departments of Genetics and Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, United States.
Doucette JT; Division of Biostatistics, Department of Environmental Medicine and Public Health, Icahn School of Medicine at Mount Sinai, New York, NY, United States.
Greenstein AJ; Department of Surgery, Icahn School of Medicine at Mount Sinai, New York, NY, United States.
Colombel JF; The Dr Henry D Janowitz Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, NY, United States.
Harpaz N; Department of Pathology, Molecular and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, United States.
Taouli B; BioMedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, NY, United States.; Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, New York, NY, United States.
Pokaż więcej
Źródło :
Journal of Crohn's & colitis [J Crohns Colitis] 2020 Dec 15. Date of Electronic Publication: 2020 Dec 15.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Therapeutic Drug Monitoring of Anti-tumour Necrosis Factor Agents in Inflammatory Bowel Diseases: The Jury Is Still Out.
Autorzy :
Agrawal M; The Dr. Henry D. Janowitz Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Dubinsky MC; Division of Pediatric Gastroenterology and Nutrition, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Colombel JF; The Dr. Henry D. Janowitz Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Pokaż więcej
Źródło :
Journal of Crohn's & colitis [J Crohns Colitis] 2020 Sep 07; Vol. 14 (8), pp. 1035-1036.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
JAK Inhibitors Safety in Ulcerative Colitis: Practical Implications.
Autorzy :
Agrawal M; Dr Henry D. Janowitz Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York NY, USA.
Kim ES; Dr Henry D. Janowitz Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York NY, USA.; Division of Gastroenterology, Department of Internal Medicine, School of Medicine, Kyungpook National University, Daegu, South Korea.
Colombel JF; Dr Henry D. Janowitz Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York NY, USA.
Pokaż więcej
Źródło :
Journal of Crohn's & colitis [J Crohns Colitis] 2020 Aug 01; Vol. 14 (Supplement_2), pp. S755-S760.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Outcomes and Strategies to Support a Treat-to-target Approach in Inflammatory Bowel Disease: A Systematic Review.
Autorzy :
Colombel JF; Inflammatory Bowel Disease Center, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
D'haens G; Amsterdam University Medical Centers - Inflammatory Bowel Disease Unit, University of Amsterdam, Amsterdam, The Netherlands.
Lee WJ; Global Gastroenterology, AbbVie, North Chicago, IL, USA.
Petersson J; Global Gastroenterology, AbbVie, North Chicago, IL, USA.
Panaccione R; Inflammatory Bowel Disease Clinic, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
Pokaż więcej
Źródło :
Journal of Crohn's & colitis [J Crohns Colitis] 2020 Feb 10; Vol. 14 (2), pp. 254-266.
Typ publikacji :
Journal Article; Systematic Review
MeSH Terms :
Patient Care Planning*
Inflammatory Bowel Diseases/*therapy
Humans ; Remission Induction ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Viewpoint: Inflammatory Bowel Diseases Among Immigrants From Low- to High-Incidence Countries: Opportunities and Considerations.
Autorzy :
Agrawal M; Dr. Henry D. Janowitz Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York NY, USA.
Burisch J; Gastrounit, Medical Division, Hvidovre Hospital, Copenhagen, Denmark.
Colombel JF; Dr. Henry D. Janowitz Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York NY, USA.
C Shah S; Division of Gastroenterology, Vanderbilt University, Nashville TN, USA.
Pokaż więcej
Źródło :
Journal of Crohn's & colitis [J Crohns Colitis] 2020 Feb 10; Vol. 14 (2), pp. 267-273.
Typ publikacji :
Journal Article
MeSH Terms :
Emigrants and Immigrants/*statistics & numerical data
Inflammatory Bowel Diseases/*epidemiology
Colitis, Ulcerative/epidemiology ; Colitis, Ulcerative/etiology ; Crohn Disease/epidemiology ; Crohn Disease/etiology ; Health Care Costs ; Humans ; Incidence ; Inflammatory Bowel Diseases/economics ; Inflammatory Bowel Diseases/etiology ; Prevalence ; Risk Factors
Czasopismo naukowe
Tytuł :
IM-UNITI: Three-year Efficacy, Safety, and Immunogenicity of Ustekinumab Treatment of Crohn's Disease.
Autorzy :
Hanauer SB; Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
Sandborn WJ; University of California San Diego, La Jolla, CA USA.
Feagan BG; Robarts Clinical Trials, Western University, London, ON, Canada.
Gasink C; Janssen Scientific Affairs, LLC, Horsham, PA, USA.
Jacobstein D; Janssen Research & Development, LLC, Spring House, PA, USA.
Zou B; Janssen Research & Development, LLC, Spring House, PA, USA.
Johanns J; Janssen Research & Development, LLC, Spring House, PA, USA.
Adedokun OJ; Janssen Research & Development, LLC, Spring House, PA, USA.
Sands BE; Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Rutgeerts P; University Hospital, Gasthuisberg, Leuven, Belgium.
de Villiers WJS; Stellenbosch University, Stellenbosch, South Africa.
Colombel JF; Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Ghosh S; NIHR Biomedical Research Centre, University Hospitals Birmingham NHS Foundation Trust and University of Birmingham, Birmingham, UK.
Pokaż więcej
Źródło :
Journal of Crohn's & colitis [J Crohns Colitis] 2020 Jan 01; Vol. 14 (1), pp. 23-32.
Typ publikacji :
Journal Article; Randomized Controlled Trial
MeSH Terms :
Crohn Disease/*drug therapy
Ustekinumab/*therapeutic use
Double-Blind Method ; Drug Administration Schedule ; Humans ; Injections, Subcutaneous ; Maintenance Chemotherapy ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Early Dose Optimisation of Golimumab in Nonresponders to Induction Treatment for Ulcerative Colitis Is Effective and Supported by Pharmacokinetic Data.
Autorzy :
Philip G; Global Clinical Development, Merck & Co., Inc., Kenilworth, NJ, USA.
Cornillie F; Global Medical Affairs, MSD International, Kriens-Luzern, Switzerland.
Adedokun JO; Immunology, Janssen Research & Development, LLC, Spring House, PA, USA.
Melsheimer R; Medical Affairs, Janssen Biologics BV, Leiden, The Netherlands.
Rutgeerts P; Department of Endoscopy, University Hospital Gasthuisberg, Leuven, Belgium.
Colombel JF; Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Marano C; Immunology, Janssen Research & Development, LLC, Spring House, PA, USA.
Pokaż więcej
Źródło :
Journal of Crohn's & colitis [J Crohns Colitis] 2019 Sep 27; Vol. 13 (10), pp. 1257-1264.
Typ publikacji :
Journal Article; Randomized Controlled Trial
MeSH Terms :
Antibodies, Monoclonal/*administration & dosage
Colitis, Ulcerative/*drug therapy
Gastrointestinal Agents/*administration & dosage
Antibodies, Monoclonal/blood ; Antibodies, Monoclonal/pharmacokinetics ; Antibodies, Monoclonal/therapeutic use ; C-Reactive Protein/analysis ; Feces/chemistry ; Gastrointestinal Agents/blood ; Gastrointestinal Agents/pharmacology ; Gastrointestinal Agents/therapeutic use ; Humans ; Leukocyte L1 Antigen Complex/analysis ; Remission Induction/methods ; Treatment Outcome ; Tumor Necrosis Factor-alpha/antagonists & inhibitors
Czasopismo naukowe
Tytuł :
Five-year Safety Data From OPUS, a European Observational Safety Registry for Adults With Ulcerative Colitis Treated With Originator Infliximab [Remicade®] or Conventional Therapy.
Autorzy :
Panés J; Department of Gastroenterology, Hospital Clínic de Barcelona, IDIBAPS, CIBERehd, Barcelona, Spain.
Lindsay JO; Department of Gastrointestinal and Liver Services, Royal London Hospital, Barts Health NHS Trust, London, UK.
Teich N; Innere Medizin/Gastroenterologie, Internistische Gemeinschaftspraxis, Leipzig, Germany.
Lindgren S; Department of Gastroenterology, Lund University, Malmo, Sweden.
Colombel JF; Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Cornillie F; Global Medical Affairs, MSD International, Kriens-Luzern, Switzerland.
Flynn HA; MRL, Merck & Co., Inc., Kenilworth, NJ, USA.
Huyck S; MRL, Merck & Co., Inc., Kenilworth, NJ, USA.
Stryszak P; MRL, Merck & Co., Inc., Kenilworth, NJ, USA.
Yao R; MRL, Merck & Co., Inc., Kenilworth, NJ, USA.
Philip G; MRL, Merck & Co., Inc., Kenilworth, NJ, USA.
Reinisch W; Klinische Abt. Gastroenterologie & Hepatologie, Universitätsklinik für Innere Medizin III, Vienna, Austria.
Pokaż więcej
Źródło :
Journal of Crohn's & colitis [J Crohns Colitis] 2019 Sep 19; Vol. 13 (9), pp. 1148-1157.
Typ publikacji :
Comparative Study; Journal Article; Observational Study
MeSH Terms :
Colitis, Ulcerative/*drug therapy
Gastrointestinal Agents/*therapeutic use
Infliximab/*therapeutic use
Adrenal Cortex Hormones/therapeutic use ; Adult ; Europe ; Female ; Gastrointestinal Agents/adverse effects ; Humans ; Immunosuppressive Agents/therapeutic use ; Infections/chemically induced ; Infliximab/adverse effects ; Male ; Product Surveillance, Postmarketing ; Prospective Studies ; Registries
Czasopismo naukowe
Tytuł :
Rapid Changes in Laboratory Parameters and Early Response to Adalimumab: A Pooled Analysis From Patients With Ulcerative Colitis in Two Clinical Trials.
Autorzy :
Hanauer S; Northwestern University, Digestive Health Centre, Chicago, IL, USA.
Sandborn WJ; University of California San Diego, Division of Gastroenterology, La Jolla, CA, USA.
Colombel JF; Icahn School of Medicine at Mount Sinai, Gastroenterology, New York, NY, USA.
Vermeire S; University Hospital Leuven, Gastroenterology, Leuven, Belgium.
Petersson J; AbbVie Inc., Global Pharmaceutical Research & Development, North Chicago, IL, USA.
Kligys K; AbbVie Inc., Global Pharmaceutical Research & Development, North Chicago, IL, USA.
Zhou Q; AbbVie Inc., Global Pharmaceutical Research & Development, North Chicago, IL, USA.
Lazar A; AbbVie Deutschland GmbH & Co. KG, Ludwigshafen, Germany.
Reinisch W; Medical University of Vienna, Department for Gastroenterology and Hepatology, Vienna, Austria.
Pokaż więcej
Źródło :
Journal of Crohn's & colitis [J Crohns Colitis] 2019 Sep 19; Vol. 13 (9), pp. 1227-1233.
Typ publikacji :
Journal Article; Randomized Controlled Trial
MeSH Terms :
Adalimumab/*therapeutic use
Anti-Inflammatory Agents/*therapeutic use
Colitis, Ulcerative/*drug therapy
Adult ; Aged ; Biomarkers/blood ; Blood Proteins/analysis ; C-Reactive Protein/analysis ; Colitis, Ulcerative/pathology ; Erythrocyte Count ; Female ; Hematocrit ; Hemoglobins/analysis ; Humans ; Intestinal Mucosa/pathology ; Male ; Middle Aged ; Platelet Count ; Quality of Life ; Serum Albumin/analysis ; Surveys and Questionnaires
Czasopismo naukowe
Tytuł :
Efficacy and Safety of Adalimumab by Disease Duration: Analysis of Pooled Data From Crohn's Disease Studies.
Autorzy :
Panaccione R; University of Calgary, Department of Medicine, Calgary, AB, Canada.
Löfberg R; IBD Unit, Karolinska Institutet, Stockholm, Sweden.
Rutgeerts P; Division of Gastroenterology, University Hospital Gasthuisberg, Leuven, Belgium.
Sandborn WJ; Division of Gastroenterology, University of California San Diego, La Jolla, CA, USA.
Schreiber S; Department of Medicine I, University Hospital Schleswig-Holstein, Kiel, Germany.
Berg S; Global Medical Affairs, AbbVie AB, Solna, Sweden.
Maa JF; Development, AbbVie Inc., North Chicago, IL, USA.
Petersson J; Global Medical Affairs, AbbVie Inc., North Chicago, IL, USA.
Robinson AM; Development, AbbVie Inc., North Chicago, IL, USA.
Colombel JF; Division of Gastroenterology, Icahn School of Medicine at Mt Sinai, New York, NY, USA.
Pokaż więcej
Źródło :
Journal of Crohn's & colitis [J Crohns Colitis] 2019 May 27; Vol. 13 (6), pp. 725-734.
Typ publikacji :
Journal Article
MeSH Terms :
Adalimumab/*therapeutic use
Anti-Inflammatory Agents/*therapeutic use
Crohn Disease/*drug therapy
Adalimumab/adverse effects ; Adult ; Anti-Inflammatory Agents/adverse effects ; Clinical Trials as Topic/statistics & numerical data ; Female ; Humans ; Male ; Time Factors ; Treatment Outcome ; Tumor Necrosis Factor-alpha/antagonists & inhibitors
Czasopismo naukowe
Tytuł :
Deep Remission With Vedolizumab in Patients With Moderately to Severely Active Ulcerative Colitis: A GEMINI 1 post hoc Analysis.
Autorzy :
Sandborn WJ; University of California San Diego, San Diego, CA, USA.; UC San Diego Health System, San Diego, CA, USA.
Colombel JF; Mount Sinai Hospital, New York, NY, USA.
Panaccione R; University of Calgary, Calgary, AB, Canada.
Dulai PS; University of California San Diego, San Diego, CA, USA.
Rosario M; Takeda Development Center Americas, Inc., Cambridge, MA, USA.
Cao C; Takeda Pharmaceuticals USA Inc., Deerfield, IL, USA.
Barocas M; Takeda Pharmaceuticals USA Inc., Deerfield, IL, USA.
Lasch K; Takeda Pharmaceuticals USA Inc., Deerfield, IL, USA.
Pokaż więcej
Źródło :
Journal of Crohn's & colitis [J Crohns Colitis] 2019 Feb 01; Vol. 13 (2), pp. 172-181.
Typ publikacji :
Journal Article; Randomized Controlled Trial
MeSH Terms :
Antibodies, Monoclonal, Humanized/*therapeutic use
Colitis, Ulcerative/*drug therapy
Gastrointestinal Agents/*therapeutic use
Adolescent ; Adult ; Aged ; Colitis, Ulcerative/pathology ; Female ; Humans ; Male ; Middle Aged ; Remission Induction/methods ; Severity of Illness Index ; Young Adult
Czasopismo naukowe
Tytuł :
Incidence of Arthritis/Arthralgia in Inflammatory Bowel Disease with Long-term Vedolizumab Treatment: Post Hoc Analyses of the GEMINI Trials.
Autorzy :
Feagan BG; Robarts Research Institute, University of Western Ontario, London, ON, Canada.
Sandborn WJ; Division of Gastroenterology, University of California San Diego, La Jolla, CA, USA.
Colombel JF; Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Byrne SO; Takeda Pharmaceuticals International AG, Zurich, Switzerland.
Khalid JM; Takeda International - UK Branch, London, UK.
Kempf C; Takeda Pharmaceuticals International AG, Zurich, Switzerland.
Geransar P; Takeda Pharmaceuticals International AG, Zurich, Switzerland.
Bhayat F; Takeda Pharmaceuticals International Co., Cambridge, MA, USA.
Rubin DT; University of Chicago Medicine Inflammatory Bowel Disease Center, Chicago, IL, USA.
Pokaż więcej
Źródło :
Journal of Crohn's & colitis [J Crohns Colitis] 2019 Jan 01; Vol. 13 (1), pp. 50-57.
Typ publikacji :
Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial
MeSH Terms :
Adrenal Cortex Hormones/*administration & dosage
Antibodies, Monoclonal, Humanized/*therapeutic use
Arthralgia/*epidemiology
Arthritis/*epidemiology
Colitis, Ulcerative/*drug therapy
Crohn Disease/*drug therapy
Gastrointestinal Agents/*therapeutic use
Disease Progression ; Humans ; Incidence
Czasopismo naukowe
Tytuł :
Integrated Care for Crohn's Disease: A Plea for the Development of Clinical Decision Support Systems.
Autorzy :
Pauwen NY; UCL: Université Catholique de Louvain - Institute of Health and Society, Belgium.
Louis E; Department of Gastroenterology University Hospital CHU Liège, Belgium.
Siegel C; Section of Gastroenterology and Hepatology, Dartmouth-Hitchcock Medical Center, Lebanon, NH, USA.
Colombel JF; Department of Gastroenterology, Icahn Medical School at Mount Sinai, New York, NY, USA.
Macq J; UCL: Université Catholique de Louvain - Institute of Health and Society, Belgium.
Pokaż więcej
Źródło :
Journal of Crohn's & colitis [J Crohns Colitis] 2018 Nov 28; Vol. 12 (12), pp. 1499-1504.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Delivery of Health Care, Integrated*/methods
Delivery of Health Care, Integrated*/organization & administration
Biological Therapy/*methods
Crohn Disease/*therapy
Decision Support Systems, Clinical/*organization & administration
Patient Participation/*methods
Clinical Decision-Making ; Decision Making ; Humans ; Secondary Prevention
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies